Population screening for liver fibrosis: Toward early diagnosis and intervention for chronic liver diseases

Pere Ginès, Laurent Castera, Frank Lammert, Isabel Graupera, Miquel Serra‐Burriel, Alina M. Allen, Vincent Wai‐Sun Wong, Phillipp Hartmann, Maja Thiele, Llorenç Caballeria, Robert J. Knegt, Ivica Grgurevic, Salvador Augustin, Emmanuel A. Tsochatzis, Jörn M. Schattenberg, Indra Neil Guha, Andrea Martini, Rosa M. Morillas, Montserrat Garcia‐Retortillo, Harry J. Koning, Núria Fabrellas, Judit Pich, Ann T. Ma, M. Alba Diaz, Dominique Roulot, Philip N. Newsome, Michael Manns, Patrick S.

Recent Improvement in Survival Outcomes and Reappraisal of Prognostic Factors in Pediatric Living Donor Liver Transplantation

Seak Hee Oh, In Sook Jeong, Dae Yeon Kim, Jung‐Man Namgoong, Won Kyoung Jhang, Seong Jong Park, Dong‐Hwan Jung, Deok Bog Moon, Gi‐Won Song, Gil‐Chun Park, Tae‐Yong Ha, Chul‐Soo Ahn, Ki‐Hun Kim, Shin Hwang, Sung Gyu Lee, Kyung Mo Kim – 17 September 2021 – Living donor liver transplantation (LDLT) is a significant advancement for the treatment of children with end‐stage liver disease given the shortage of deceased donors. The ultimate goal of pediatric LDLT is to achieve complete donor safety and zero recipient mortality.

Subscribe to